First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 4.04 USD Market Closed
Updated: Feb 24, 2024

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Feb 24, 2024.

Estimated DCF Value of one ADPT stock is -10.32 USD. Compared to the current market price of 4.04 USD, the stock is Overvalued by 100%.

ADPT DCF Value
Base Case
-10.32 USD
Overvaluation 100%
DCF Value
Price
Worst Case
Base Case
Best Case
-10.32
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: -10.32 USD

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to -525.3m USD. The present value of the terminal value is -969m USD. The total present value equals -1.5B USD.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value -1.5B USD
Equity Value -1.5B USD
/ Shares Outstanding 144.8m
ADPT DCF Value -10.32 USD
Overvalued by 100%

You are using the equity valuation model. In this approach, further calculations for converting firm value to equity value are not required. The present value, obtained in the present value calculation block, already represents the equity value.

The DCF value per share is derived by dividing the present value by the number of shares:

Present Value
-1.5B USD
/
Number of Shares
144.8m
=
DCF Value
-10.32 USD

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
229.8m 486.4m
Net Income
-162.4m -140.1m

See Also

Discover More

What is the DCF value of one ADPT stock?

Estimated DCF Value of one ADPT stock is -10.32 USD. Compared to the current market price of 4.04 USD, the stock is Overvalued by 100%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Adaptive Biotechnologies Corp's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at -1.5B USD.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of -10.32 USD per share.

//